128 related articles for article (PubMed ID: 1131622)
1. Reduced secretory antibody response to live attenuated measles and poliovirus vaccines in malnourished children.
Chandra RK
Br Med J; 1975 Jun; 2(5971):583-5. PubMed ID: 1131622
[TBL] [Abstract][Full Text] [Related]
2. Mucosal IgA responses in healthy adult volunteers following intranasal spray delivery of a live attenuated measles vaccine.
Simon JK; Ramirez K; Cuberos L; Campbell JD; Viret JF; Muñoz A; Lagos R; Levine MM; Pasetti MF
Clin Vaccine Immunol; 2011 Mar; 18(3):355-61. PubMed ID: 21228137
[TBL] [Abstract][Full Text] [Related]
3. II. Primary and secondary immunological response of experimental animals to attenuated and nonattenuated measles virus.
Aleksandrowicz J; Polna I; Sadowski W
Acta Microbiol Pol A; 1973; 5(3):139-45. PubMed ID: 4203633
[No Abstract] [Full Text] [Related]
4. Response to live attenuated measles vaccine in children with severe kwashiorkor.
Powell GM
Ann Trop Paediatr; 1982 Sep; 2(3):143-5. PubMed ID: 6191631
[TBL] [Abstract][Full Text] [Related]
5. Combined administration of measles, mumps, rubella, and trivalent oral poliovirus vaccines.
Krugman RD; Witte JJ; Parkman PD; Herrmann KL; Meyer HM; Wende RD; Meyer BC; Dungca R
Public Health Rep; 1977; 92(3):220-2. PubMed ID: 866558
[No Abstract] [Full Text] [Related]
6. [On the simultaneous use of live-virus vaccines, for example measles-polio vaccine].
Böthig B; Gerike E; Starke G; Giesecke H
Rev Roum Virol (1972); 1974; 25(1):15-21. PubMed ID: 4410266
[No Abstract] [Full Text] [Related]
7. Antibody responses in serum and nasal secretions of children immunized with inactivated and attenuated measles-virus vaccines.
Bellanti JA; Sanga RL; Klutinis B; Brandt B; Artenstein MS
N Engl J Med; 1969 Mar; 280(12):628-33. PubMed ID: 4179401
[No Abstract] [Full Text] [Related]
8. Effect of concurrent viral infection on systemic and local antibody responses to live attenuated and enhanced-potency inactivated poliovirus vaccines.
Faden H; Duffy L
Am J Dis Child; 1992 Nov; 146(11):1320-3. PubMed ID: 1415071
[TBL] [Abstract][Full Text] [Related]
9. Secretory immune response after nasal vaccination with live attenuated influenza viruses.
Crifö S; Vella S; Filiaci F; Resta S; Rocchi G
Rhinology; 1980 Jun; 18(2):87-92. PubMed ID: 7403787
[TBL] [Abstract][Full Text] [Related]
10. [Measurement of the in vitro immune response of live attenuated measles virus vaccine and antibody levels in 0 to 10-year-old children].
Unalan H; Ustaçelebi S
Mikrobiyol Bul; 1985 Oct; 19(4):218-28. PubMed ID: 3831724
[TBL] [Abstract][Full Text] [Related]
11. Oral iodine supplementation does not reduce neutralizing antibody responses to oral poliovirus vaccine.
Taffs RE; Enterline JC; Rusmil K; Muhilal ; Suwardi SS; Rustama D; Djatnika ; Cobra C; Semba RD; Cohen N; Asher DM
Bull World Health Organ; 1999; 77(6):484-91. PubMed ID: 10427933
[TBL] [Abstract][Full Text] [Related]
12. [Response of revaccination against polio I in seronegative children after receiving 3 or more doses of the vaccine].
Ruiz-Gómez J; Sánchez Burgos Y; Arrayales Sandoval F; Velázquez Zúñiga C
Gac Med Mex; 1977 Jan; 113(1):23-7. PubMed ID: 863152
[No Abstract] [Full Text] [Related]
13. CURRENT STATUS OF MEASLES AND ORAL POLIOVIRUS VACCINES.
MACLEOD DR
Can Med Assoc J; 1964 Nov; 91(21):1118-22. PubMed ID: 14229761
[TBL] [Abstract][Full Text] [Related]
14. Measles vaccination in severely malnourished Sudanese children.
Idris S; El Seed AM
Ann Trop Paediatr; 1983 Jun; 3(2):63-7. PubMed ID: 6197010
[TBL] [Abstract][Full Text] [Related]
15. Experimental study of a further attenuated live measles vaccine of the Sugiyama strain in Iran.
Mirchamsy H; Shafyi A; Rafyi MR; Bahrami S; Nazari P; Fatemie S
J Hyg (Lond); 1974 Apr; 72(2):273-9. PubMed ID: 4522721
[TBL] [Abstract][Full Text] [Related]
16. Co-administration study in South African infants of a live-attenuated oral human rotavirus vaccine (RIX4414) and poliovirus vaccines.
Steele AD; De Vos B; Tumbo J; Reynders J; Scholtz F; Bos P; de Beer MC; Van der Merwe CF; Delem A
Vaccine; 2010 Sep; 28(39):6542-8. PubMed ID: 18786585
[TBL] [Abstract][Full Text] [Related]
17. Booster vaccination with further live attenuated measles vaccine.
Bass JW; Halstead SB; Fischer GW; Podgore JK; Pearl WR; Schydlower M; Wiebe RA; Ching FM
JAMA; 1976 Jan; 235(1):31-4. PubMed ID: 945997
[TBL] [Abstract][Full Text] [Related]
18. Trial of a reduced dose of measles vaccine in Nigerian children.
Wallace RB; Landrigan PJ; Smith EA; Pifer J; Teller B; Foster SO
Bull World Health Organ; 1976; 53(4):361-4. PubMed ID: 1086728
[TBL] [Abstract][Full Text] [Related]
19. The response of children to a reduced dose of measles vaccine given with and without other vaccines. (pilot study).
Cruickshank JG; Dalton H; Lochrie G; Campbell I
Cent Afr J Med; 1974 Oct; 20(10):201-2. PubMed ID: 4426084
[No Abstract] [Full Text] [Related]
20. Virus-specific IgA in serum, saliva, and tears of children with measles.
Friedman MG; Phillip M; Dagan R
Clin Exp Immunol; 1989 Jan; 75(1):58-63. PubMed ID: 2495200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
